RENACER - Brain Metastasis Network
@renacerbrainmet.bsky.social
Creating a new paradigm for Brain Metastasis through the development of new personalised cancer therapeutic approaches.
High pSTAT3 in reactive astrocytes is linked to higher intracranial recurrence and shorter PFS in triple-negative #BreastCancer #BrainMetastases. STAT3 emerges as a potential prognostic biomarker and therapeutic target.
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome - PubMed
This study indicates that STAT3 expression prevails in reactive astrocytes surrounding triple-negative BrM in comparison to HER2-positive and luminal BrM, and these findings mirror those observed in…
pubmed.ncbi.nlm.nih.gov
November 13, 2025 at 1:24 PM
High pSTAT3 in reactive astrocytes is linked to higher intracranial recurrence and shorter PFS in triple-negative #BreastCancer #BrainMetastases. STAT3 emerges as a potential prognostic biomarker and therapeutic target.
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
Manuel Valiente shared with the researchers at the CNIO the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance
November 5, 2025 at 10:13 AM
Manuel Valiente shared with the researchers at the CNIO the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance
🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
October 26, 2025 at 9:01 AM
🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Everything is ready for the 5th RENACER General Assembly at the Ramón Areces Foundation! We look forward to welcoming clinicians, researchers, patient representatives, and collaborators to share the latest advances in brain metastases.
October 24, 2025 at 8:13 AM
Everything is ready for the 5th RENACER General Assembly at the Ramón Areces Foundation! We look forward to welcoming clinicians, researchers, patient representatives, and collaborators to share the latest advances in brain metastases.
Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence.
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach - PubMed
Metastasis is the process through which cancer cells break away from a primary tumor, travel through the blood or lymph system, and form new tumors in distant tissues. One of the preferred sites for…
pubmed.ncbi.nlm.nih.gov
October 16, 2025 at 9:30 AM
Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence.
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment.
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
October 11, 2025 at 8:30 AM
At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment.
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
September 29, 2025 at 3:47 PM
🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...
AEMPS
AEMPS Email Forms
gob.us4.list-manage.com
September 19, 2025 at 10:02 AM
🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...
📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks.
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values? | Biopreservation and Biobanking
Biobanks are important resources for improving public health and individual care. Some legal frameworks can be more or less conducive to advancing the potential benefits of biobanks. The purpose of…
doi.org
September 8, 2025 at 8:02 AM
📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks.
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
🧠 Save the Date!
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
August 28, 2025 at 9:01 AM
🧠 Save the Date!
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw
August 25, 2025 at 8:01 AM
🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw
“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.
August 19, 2025 at 7:03 AM
“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.
The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊
🔗 canceratlas.cancer.org
🔗 canceratlas.cancer.org
Cancer Atlas
Exposures to numerous potentially modifiable risk factors for cancer vary substantially across and within countries and are often associated with socioeconomic status.
canceratlas.cancer.org
August 5, 2025 at 9:02 AM
The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊
🔗 canceratlas.cancer.org
🔗 canceratlas.cancer.org
Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay
🔗 Full interview:
🔗 Full interview:
20 años de ciencia transformadora: el legado de los Premios Fundación Banco Sabadell.
Coincidiendo con la edición número 20, la Fundación ha impulsado “Conversaciones con Ciencia”, que otorgan la palabra a algunos de los investigadores galardonados con el premio en las ediciones…
www.elperiodico.com
July 22, 2025 at 8:01 AM
Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay
🔗 Full interview:
🔗 Full interview:
🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
July 14, 2025 at 7:30 AM
🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
July 9, 2025 at 8:02 AM
The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
At #RENACER, we support research that brings us closer to personalised treatments. This study led by Zhu et al. uses organotypic cultures to identify vulnerabilities in brain metastases. A major step forward!
🔗 pubmed.ncbi.nlm.nih.gov/35174975/
🔗 pubmed.ncbi.nlm.nih.gov/35174975/
June 23, 2025 at 9:23 AM
At #RENACER, we support research that brings us closer to personalised treatments. This study led by Zhu et al. uses organotypic cultures to identify vulnerabilities in brain metastases. A major step forward!
🔗 pubmed.ncbi.nlm.nih.gov/35174975/
🔗 pubmed.ncbi.nlm.nih.gov/35174975/
The 2025 EACR Congress is the key meeting for cancer researchers tackling brain metastases. Topics like tumour evolution & immune evasion are vital for advancing personalised medicine. RENACER is proud to connect teams driving this progress. 🧬 🔗 2025.eacr.org
EACR 2025 Congress: Innovative Cancer Science | EACR2025
2025.eacr.org
June 17, 2025 at 5:56 AM
The 2025 EACR Congress is the key meeting for cancer researchers tackling brain metastases. Topics like tumour evolution & immune evasion are vital for advancing personalised medicine. RENACER is proud to connect teams driving this progress. 🧬 🔗 2025.eacr.org
We are very excited to share this article from focused on our work to treat brain metastasis. With the participation of patients, professionals, and project leaders, the article highlights the challenges of treating this disease and the progress being made.
www.elmundo.es/ciencia-y-sa...
www.elmundo.es/ciencia-y-sa...
Así luchan contra el cáncer la metástasis de Pepe y de otros 400 españoles: "Los tumores llegan vivos al laboratorio"
«El primer día que ves un cerebro no se te olvida», dice Guillermo Blasco mientras retira con sumo cuidado la meninge que acaba de cortar. El neurocirujano del...
www.elmundo.es
June 11, 2025 at 8:05 AM
We are very excited to share this article from focused on our work to treat brain metastasis. With the participation of patients, professionals, and project leaders, the article highlights the challenges of treating this disease and the progress being made.
www.elmundo.es/ciencia-y-sa...
www.elmundo.es/ciencia-y-sa...
This year’s #NMNSymposium spotlighted key advances in #neurooncology: from single-cell tech to AI imaging and immunotherapy. Topics that resonate deeply with our work at #RENACER.
🔗 www.nmn-society.org/program/%E2%...
🔗 www.nmn-society.org/program/%E2%...
https://www.nmn-society.org/program/
June 5, 2025 at 8:05 AM
This year’s #NMNSymposium spotlighted key advances in #neurooncology: from single-cell tech to AI imaging and immunotherapy. Topics that resonate deeply with our work at #RENACER.
🔗 www.nmn-society.org/program/%E2%...
🔗 www.nmn-society.org/program/%E2%...
🧠 At #ASCO2025, Dr Juan Manuel Sepúlveda (Hospital 12 de Octubre & #RENACER) presented early results from the CAN-201 NDG trial testing azeliragon + standard care in glioblastoma.
📄 ascopubs.org/doi/pdf/10.1...
#NeuroOncology #ClinicalResearch #TranslationalMedicine
📄 ascopubs.org/doi/pdf/10.1...
#NeuroOncology #ClinicalResearch #TranslationalMedicine
June 3, 2025 at 3:36 PM
🧠 At #ASCO2025, Dr Juan Manuel Sepúlveda (Hospital 12 de Octubre & #RENACER) presented early results from the CAN-201 NDG trial testing azeliragon + standard care in glioblastoma.
📄 ascopubs.org/doi/pdf/10.1...
#NeuroOncology #ClinicalResearch #TranslationalMedicine
📄 ascopubs.org/doi/pdf/10.1...
#NeuroOncology #ClinicalResearch #TranslationalMedicine
Today on #ClinicalTrialsDay, we highlight their key role in advancing medicine. At #RENACER, we’re building the knowledge needed for future trials in brain metastases, a cancer complication still lacking effective treatments. 🧠
May 20, 2025 at 11:19 AM
Today on #ClinicalTrialsDay, we highlight their key role in advancing medicine. At #RENACER, we’re building the knowledge needed for future trials in brain metastases, a cancer complication still lacking effective treatments. 🧠
Brain metastases are major challengein oncology. At RENACER, we are changing this with a unique workflow to collect, analyse, and classify them. Our approachdrives better treatmentsand outcomes. Discovermore in ournew infographic!
🔗 renacerbrainmet.org/renacer/
🔗 renacerbrainmet.org/renacer/
RENACER – Renacer Brain Met
renacerbrainmet.org
May 15, 2025 at 9:11 AM
Brain metastases are major challengein oncology. At RENACER, we are changing this with a unique workflow to collect, analyse, and classify them. Our approachdrives better treatmentsand outcomes. Discovermore in ournew infographic!
🔗 renacerbrainmet.org/renacer/
🔗 renacerbrainmet.org/renacer/
We welcome
@hospitaldelmar.bsky.social
and Hospital Clínico Universitario de Santiago to our growing network! 🏥🧠
With 21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care.
🔗 renacerbrainmet.org/es/miembros-...
@hospitaldelmar.bsky.social
and Hospital Clínico Universitario de Santiago to our growing network! 🏥🧠
With 21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care.
🔗 renacerbrainmet.org/es/miembros-...
Miembros y coordinadores – Renacer Brain Met
renacerbrainmet.org
May 8, 2025 at 8:21 AM
We welcome
@hospitaldelmar.bsky.social
and Hospital Clínico Universitario de Santiago to our growing network! 🏥🧠
With 21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care.
🔗 renacerbrainmet.org/es/miembros-...
@hospitaldelmar.bsky.social
and Hospital Clínico Universitario de Santiago to our growing network! 🏥🧠
With 21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care.
🔗 renacerbrainmet.org/es/miembros-...
🧬 On #InternationalDNADay, we highlight a key challenge in oncology: the genetic diversity of tumours. At RENACER, we are working to turn these discoveries into personalised therapies.
Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/
Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/
April 25, 2025 at 8:02 AM
🧬 On #InternationalDNADay, we highlight a key challenge in oncology: the genetic diversity of tumours. At RENACER, we are working to turn these discoveries into personalised therapies.
Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/
Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/